Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sustainable Preservation of Essential Oxygen Resources: A Phase 4 Crossover Study of the Efficacy, Tolerability and SpO2 Non-inferiority of the BUFEO System: SAVE O2

NCT05677009 is registered in ClinicalTrials.gov with Oxfo Corporation as lead sponsor.

NCT NCT05677009
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05677009 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sustainable Preservation of Essential Oxygen Resources: A Phase 4 Crossover Study of the Efficacy, Tolerability and SpO2 Non-inferiority of the BUFEO System: SAVE O2
Lead sponsor
Oxfo Corporation
Phase
Not applicable
Overall status
Completed
Start date
November 4, 2022
Completion date
December 17, 2022
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

oxygen deficiency, oxygen therapy